| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-05 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-05 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.25 | 5e-05 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-05 |